Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patients with advanced multiple myeloma

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB
[thumbnail of Data Supplements]
Preview
PDF (Data Supplements) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
128kB

Item Type:Letter
Title:A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patients with advanced multiple myeloma
Creators Name:Krüger, J., Obenaus, M., Blau, I.W., Hoser, D., Vaegler, M., Rauschenbach, H., Anagnostopoulos, I., Jöhrens, K., Scheuplein, V., Kieback, E., Böhme, J., Von Brünneck, A.C., Krönke, J., Busse, A., Willimsky, G., Blankenstein, T., Pezzutto, A., Keller, U. and Nogai, A.
Keywords:Multiple Myeloma, MAGE-A1, T Cell Receptor (TCR), TCR T Cell Therapy
Source:Haematologica
ISSN:0390-6078
Publisher:Ferrata Storti Foundation
Volume:110
Number:1
Page Range:244-250
Date:January 2025
Official Publication:https://doi.org/10.3324/haematol.2024.286124
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library